SanaHeal
SanaHeal is dedicated to developing next-generation bioadhesive technologies inspired by nature to solve significant challenges in healthcare. Their innovative solutions are designed to adhere to wet and uneven surfaces, providing rapid and robust adhesion for various medical applications.
Industries
Nr. of Employees
small (1-50)
SanaHeal
Hatch.Bio Labs, 100 Chestnut St, Somerville, MA 02143
Products
Hemostatic bioadhesive paste (research prototype)
Research-stage adhesive paste designed to provide rapid, coagulation-independent control of bleeding and form fluid-tight seals on wet tissue.
Bioadhesive patch for organ injury sealing (research prototype)
Patch-form adhesive designed to provide rapid, fluid- and air-tight sealing of organ injuries in preclinical settings.
Dry double-sided adhesive tape for wet tissues (research prototype)
Dry adhesive tape technology engineered to adhere to wet tissues and devices, enabling device fixation and wet-surface adhesion in research contexts.
Hemostatic bioadhesive paste (research prototype)
Research-stage adhesive paste designed to provide rapid, coagulation-independent control of bleeding and form fluid-tight seals on wet tissue.
Bioadhesive patch for organ injury sealing (research prototype)
Patch-form adhesive designed to provide rapid, fluid- and air-tight sealing of organ injuries in preclinical settings.
Dry double-sided adhesive tape for wet tissues (research prototype)
Dry adhesive tape technology engineered to adhere to wet tissues and devices, enabling device fixation and wet-surface adhesion in research contexts.
Expertise Areas
- Bioadhesive materials development
- Preclinical testing and validation
- Hemostasis and surgical bleeding control
- Wound care and tissue sealing
Key Technologies
- Hydrogel-based bioadhesives
- Swelling-activated adhesives
- Hemostatic adhesive pastes
- Bioadhesive patches
Key People
News & Updates
SanaHeal received the Execution Award at the MedTech Conference in Toronto.
SanaHeal was awarded a grant for the commercialization of a next-generation solution for surgical bleeding control in collaboration with Mayo Clinic and BWH, Harvard Medical School.
SanaHeal has been selected for the 2024 Ray of Hope Accelerator cohort.
SanaHeal won the first prize at the 2024 iCANX Startup Award.
SanaHeal has been selected for the 2024 MedTech Innovator cohort.
SanaHeal received patent issuance for their innovative bioadhesive technologies.
SanaHeal received the Execution Award at the MedTech Conference in Toronto.
SanaHeal was awarded a grant for the commercialization of a next-generation solution for surgical bleeding control in collaboration with Mayo Clinic and BWH, Harvard Medical School.
SanaHeal has been selected for the 2024 Ray of Hope Accelerator cohort.
SanaHeal won the first prize at the 2024 iCANX Startup Award.
SanaHeal has been selected for the 2024 MedTech Innovator cohort.
SanaHeal received patent issuance for their innovative bioadhesive technologies.